Similar to IGF-1, prostaglandin E2 (PGE2) is highly expressed in CRC cells during tumorigenesis and is also considered a target for RES to effectuate inhibition of Wnt β-catenin signaling-mediated cell proliferation [105]. This evidence concerns the gene IGF1 and colorectal carcinoma.